Search Results - "Jongerius, John M."

Identification of a novel single‐nucleotide mutation in SMIM1 gene that results in low Vel antigen expression by Rijst, Marea V.E., Voorn, Lesley, Veldhuisen, Barbera, Jongerius, John M., Akker, Emile, Schoot, C. Ellen

Get full text

Development of a recombinant anti‐Vel immunoglobulin M to identify Vel‐negative donors by van der Rijst, Marea V.E., Lissenberg‐Thunnissen, Suzanne N., Ligthart, Peter C., Visser, Remco, Jongerius, John M., Voorn, Lesley, Veldhuisen, Barbera, Vidarsson, Gestur, van den Akker, Emile, van der Schoot, C. Ellen

“…BACKGROUND Alloimmunization against the high‐frequency Vel blood group antigen may result in transfusion reactions or hemolytic disease of fetus and newborn…”
Get full text

Development and validation of a universal blood donor genotyping platform: a multinational prospective study by Gleadall, Nicholas S., Veldhuisen, Barbera, Gollub, Jeremy, Butterworth, Adam S., Ord, John, Penkett, Christopher J., Timmer, Tiffany C., Sauer, Carolin M., van der Bolt, Nieke, Brown, Colin, Brugger, Kim, Dilthey, Alexander T., Duarte, Daniel, Grimsley, Shane, van den Hurk, Katja, Jongerius, John M., Luken, Jessie, Megy, Karyn, Miflin, Gail, Nelson, Christopher S., Prinsze, Femmeke J., Sambrook, Jennifer, Simeoni, Ilenia, Sweeting, Michael, Thornton, Nicole, Trompeter, Sara, Tuna, Salih, Varma, Ram, Walker, Matthew R., Danesh, John, Roberts, David J., Ouwehand, Willem H., Stirrups, Kathleen E., Rendon, Augusto, Westhoff, Connie M., Di Angelantonio, Emanuele, van der Schoot, C. Ellen, Astle, William J., Watkins, Nicholas A., Lane, William J.

“…Each year, blood transfusions save millions of lives. However, under current blood-matching practices, sensitization to non–self-antigens is an unavoidable…”
Get full text

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening by Jongerius, John M., Sjerps, Margret, Cuijpers, H. Theo M., Van Drimmelen, Harry A.J., Van der Poel, Cees L., Reesink, Henk W., Molijn, M. Hans J., Peeters, Geert A.H., Peeters, Ton P.W., Lelie, P. Nico

“…BACKGROUND : Routine HCV NAT minipool screening (48 donations) of all blood donations was implemented in July 1999 and was combined with HIV NAT in November…”
Get full text

GB Virus Type C Viremia and Envelope Antibodies among Population Subsets in The Netherlands by Jongerius, J.M., Boland, G.J., van der Poel, C.L., Rasch, M.C., Italiaander, E., van der Reijden, J.J., Friedman, P.N., Cockerill, J.J., van Leeuwen, E.F., van Hattum, J.

“…Background and Objectives: Two new flaviviruses, hepatitis G virus and GB virus type C (GBV–C), are possible causative agents for non–A–E hepatitis. In this…”
Get full text

A Simple Strategy to Look Back on Posttransfusion Hepatitis B in a Multitransfused Patient by Jongerius, J.M., van der Poel, C. L., van Leeuwen, E. F.

“…Background and Objectives: In January 1996, a case of hepatitis B virus (HBV) seroconversion in a multitransfused patient was reported to the blood bank. From…”
Get full text

Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O by Jongeriüs, John M., van der Poel, Cees L., Van Loon, Anton M., van den Akker, Ruud, Schaasberg, Wim, Van Leeuwen, Eleonore F.

“…BACKGROUND: Human immunodeficiency virus type 1 (HIV‐1) subtype O infections are not reliably detected by commonly used anti‐HIV‐1/2 screening assays…”
Get full text